IP Library Granted Patent US 7,678,249
Granted Patent B2
US 7,678,249 · App. 11/213,961 · Granted Mar 16, 2010

Instrument and system for pharmacologic measurement and well vessel used therein

Assignee: Panasonic Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,678,249
App. No.
11/213,961
Granted
Mar 16, 2010
Kind
B2
Abstract

An instrument is provided for pharmacologic measurement capable of detecting a very small and short time change in electric signal caused by a pharmacologic action of a biologic specimen with quickness and a high sensitivity by steeply decreasing an external disturbance component mixed into the system while dropping/exchange of medicinal solutions is conducted in a batch mode. The pharmacologic measurement instrument detects a change in electric signal caused by a pharmacologic action or electrophysiologic action of a biologic specimen, and includes an electrically conductive box having an opening section at the top surface thereof, and a well vessel disposed in the opening section thereof, wherein the well vessel includes a base having recesses in which the biologic specimens are put; measurement electrodes formed on the bottom surfaces of the respective recesses; and reference electrodes electrically insulated from the respective measurement electrodes, and the reference electrodes together with the electrically conductive box electrostatically shields the well vessel.

Claims (31)

1. A pharmacologic measurement instrument for detecting an electric signal caused by a pharmacologic action or electrophysiologic action of a biologic specimen, said pharmacologic measurement instrument comprising:

an electrically conductive box provided with an opening section; and

a well vessel disposed in said opening section of said electrically conductive box,

wherein said well vessel comprises:

a base substrate having a top surface and a plurality of well recesses, said plurality of well recesses being configured to hold biologic specimens;

a plurality of measurement electrodes provided on bottom surfaces or back surfaces of respective well recesses of said plurality of well recesses; and

a plurality of reference electrodes electrically insulated from respective measurement electrodes of said plurality of measurement electrodes, said plurality of reference electrodes being electrically connected to said electrically conductive box,

wherein said reference electrodes cover said top surface of said base substrate and extend into said plurality of well recesses such that an upper portion of each of said respective well recesses is covered and a lower portion of each of said respective well recesses is not covered.

2. The pharmacologic measurement instrument according to claim 1 , further comprising a plurality of injection/discharge devices each capable of injecting and discharging a solution containing the biologic specimen into a corresponding well recess, said plurality of injection/discharge devices being arranged in a sliding manner to inject the solution into said plurality of well recesses.

3. The pharmacologic measurement instrument according to claim 1 , further comprising first signal amplification sections electrically connected to said respective measurement electrodes, said first signal amplification sections being arranged in said electrically conductive box.

4. A pharmacologic measurement system which comprises:

the pharmacologic measurement instrument according to claim 3 ; and

a calculation section data-processing a signal amplified in each of said first signal amplification sections.

5. The pharmacologic measurement system according to claim 4 , comprising a second signal amplification section for further amplifying an output signal from each of said measurement electrodes, already amplified in the corresponding first amplification section, while causing band limitation thereto.

6. The pharmacologic measurement system according to claim 4 , further comprising an electric stimulus generator for applying a desired current at a desired timing to each of said measurement electrodes.

7. The pharmacologic measurement system according to claim 4 , further comprising a measurement environment adjustment apparatus adjusting a temperature, a humidity, and a gas concentration of the pharmacologic measurement instrument to respective desired values.

8. The pharmacologic measurement instrument according to claim 1 , wherein an insulating section is provided between each of said measurement electrodes and the corresponding reference electrode,

and wherein the insulating sections have no toxicity to the biologic specimens.

9. The pharmacologic measurement instrument according to claim 1 , wherein each of said well recesses is tapered such that a diameter thereof increasing toward said to surface;

wherein each of said reference electrodes is provided at a corresponding recess sidewall, and

wherein a corresponding insulating section is provided between each measurement electrode and each reference electrode by removing a part of said reference electrode in a vicinity of said corresponding recess sidewall and adjacent to said measurement electrode.

10. The pharmacologic measurement instrument according to claim 1 , wherein at least one through hole is provided in a bottom surface of each of said well recesses, and

wherein each of said respective measurement electrodes is arranged in a respective through hole of said at least one through holes so as to connect to a biological specimen.

11. The pharmacologic measurement instrument according to claim 1 , further comprising suction means guiding the biologic specimen into a corresponding through hole of said at least one through hole.

12. The pharmacologic measurement instrument according to claim 1 , wherein said pharmacologic measurement instrument is configured such that a solution to be accommodated in a well recess can be exchanged for another solution.

13. The pharmacologic measurement instrument according to claim 1 , wherein said well vessel is mountable or demountable through said opening section of said electrically conductive box and is disposable.

14. The pharmacologic measurement instrument according to claim 1 , wherein said respective well recesses are configured to hold the biologic specimens respectively in said lower portion of each of said respective well recesses.

15. The pharmacologic measurement instrument according to claim 1 , wherein said reference electrodes are formed all over said top surface of said base substrate except for an area in a vicinity of a bottom surface of each of the well recesses.

16. The pharmacologic measurement instrument according to claim 1 , wherein a total surface area of said reference electrodes is at least five times as large as a surface area of said measurement electrodes.

17. The pharmacologic measurement instrument according to claim 1 , wherein said reference electrodes extend into said plurality of well recesses such that a distal portion of each of said reference electrodes submersed in a measurement solution and a top portion of each of said measurement electrodes is not submersed in the measurement solution.

18. The pharmacologic measurement instrument according to claim 1 , wherein said reference electrodes are electrically connected to said electrically conductive box at said opening section.

Assignments (2)
CHANGE OF NAME Recorded Nov 19, 2008
From: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
To: PANASONIC CORPORATION
Reel/Frame 021858/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2005
From: OZAKI, NOBUHIKO; OKA, HIROAKI
To: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
Reel/Frame 016624/0260 →
Priority Claims (1)
JP 2003-184161 · Jun 27, 2003 · national
Continuity (2)
Continuation PCTJP200400868500 · Jun 15, 2004
Related Publication 20050279634A1 · Dec 22, 2005